Novo Nordisk has reported favorable news concerning its Wegovy pill, which has positively influenced both its earnings and share price.
In related news, Vivek Ramaswamy has emerged victorious in the GOP primary for Ohio governor.
Additionally, CellCentric has successfully raised $220 million for a myeloma drug, marking significant progress in the biotech sector.